Ann Elizabeth Sisk

机构：Memorial Sloan Kettering Cancer Center

发表论文 4 篇 · 总被引 518 次 · h-index 3

代表论文

• Diverse alterations associated with resistance to KRAS(G12C) inhibition (2021 · Nature · 被引 470)
• Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment (2022 · Cancer Medicine · 被引 44)
• Responsiveness of different MET tumour alterations to type I and type II MET inhibitors (2025 · Clinical and Translational Medicine · 被引 3)
• Abstract 5239: Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation (2022 · Cancer Research · 被引 2)